The trademark application NAMSTEYA was filed by Emalex Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 25, 2024, and still open for oppositions.
The application was filed in English (Spanish was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome
Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation
Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders.